The trial is conducted at the Mays Cancer Center, part of the University of Texas at San Antonio’s Health Science Center.

Indian researchers reveal how immune cells 'betray' the body, aiding breast cancer spread and suggesting new treatment ...

Biosion, Inc. ("Biosion"), a global, clinical-stage biotechnology company developing innovative antibody-based therapeutics, today announced that the first patient has been dosed in a Phase 1a/1b ...

CD47 expression levels may predict evorpacept efficacy in HER2-positive metastatic breast cancer, especially in heavily pretreated patients. Evorpacept combined with zanidatamab shows promising ...

Together, these attributes position HCB101 as a differentiated innate immune checkpoint backbone with broad potential for a wide variety of combination strategies across solid tumors and hematologic ...

Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

DIMAPUR — A research team lead by Nagaland University (NU) along with leading national research institutions, have published ...

How does origami-like DNA affect brain development? How do cancer-immune cell interactions prevent immune cell activity in tumors?Two breakthrough ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with NSCLC, RCC, colorectal cancer ...

The market for TIGIT inhibitors is expected to grow significantly in the coming years. This is due to the increasing number ...

Tuberculosis bacteria survive by hiding in our immune cells. In her PhD research, biologist Salomé Muñoz Sánchez explores how ...